Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Michael Carome"'
Publikováno v:
PLoS ONE, Vol 11, Iss 2, p e0147800 (2016)
Little information exists on U.S. physicians who have been disciplined with licensure or restriction-of-clinical-privileges actions or have had malpractice payments because of sexual misconduct. Our objectives were to: (1) determine the number of the
Externí odkaz:
https://doaj.org/article/322ce01ee6c44b46889e52a795463af2
Publikováno v:
Public Health Nursing (Boston, Mass.)
Objective The objective of this study was to examine nurse sexual‐misconduct–related reports in the National Practitioner Data Bank (NPDB) and to compare them with reports for other types of offenses. Design and Population We analyzed NPDB’s re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a6d6248d4ba029cdb32f06f5f931311
https://doi.org/10.1111/phn.12567
https://doi.org/10.1111/phn.12567
Publikováno v:
Open Access Journal of Clinical Trials. 10:19-28
Sarah Sorscher, Azza AbuDagga, Sammy Almashat, Michael A Carome, Sidney M Wolfe Health Research Group, Public Citizen, Washington, DC, USA Purpose: The Food and Drug Administration (FDA) permits investigators to withhold active interventions from hum
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f0e3df9fdc2f89c24a3609d932c697af
https://doi.org/10.2147/oajct.s156054
https://doi.org/10.2147/oajct.s156054
Autor:
Michael Carome, Sammy Almashat
Publikováno v:
Journal of Law, Medicine & Ethics. 45:46-49
The Food and Drug Administration (FDA), as a matter of long-standing policy, does not inform the public of instances whereby applications for new drugs or new indications for existing drugs have been rejected by the agency or withdrawn from considera
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cecbd8d9be96b5e2b6c71478089c4dda
https://doi.org/10.1177/1073110517750621
https://doi.org/10.1177/1073110517750621
Publikováno v:
J Gen Intern Med
Despite the strict prohibition against all forms of sexual relations between physicians and their patients, some physicians cross this bright line and abuse their patients sexually. The true extent of sexual abuse of patients by physicians in the U.S
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d25d49608d6acc3ccd600b4b72e88fde
https://pubmed.ncbi.nlm.nih.gov/31044409
https://pubmed.ncbi.nlm.nih.gov/31044409
Autor:
Michael Carome, Nathan Favini, Steffie Woolhandler, Mayce Mansour, David U. Himmelstein, Sidney Wolfe
Publikováno v:
American journal of public health. 107(8)
An editorial is presented which addresses the authors' claim that patients should have the right to know about payments made by accountable care organizations to physicians in America as of 2017, and it mentions physician payment arrangements involvi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::37901e6d1f5eecd19df05b0071516a41
https://pubmed.ncbi.nlm.nih.gov/28700294
https://pubmed.ncbi.nlm.nih.gov/28700294
Autor:
Robert L. Danner, Michael Carome, Irene Cortés-Puch, Sidney M. Wolfe, Robert Wesley, Charles Natanson
Publikováno v:
PLoS ONE
PLoS ONE, Vol 11, Iss 5, p e0155005 (2016)
PLoS ONE, Vol 11, Iss 5, p e0155005 (2016)
Objective The adequacy of informed consent in the Surfactant, Positive Pressure, and Pulse Oximetry Randomized Trial (SUPPORT) has been questioned. SUPPORT investigators and publishing editors, heads of government study funding agencies, and many eth
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::719e005cfb8c3d00985ec88ea2f4a6c2
http://europepmc.org/articles/PMC4871545
http://europepmc.org/articles/PMC4871545
Autor:
Michael Carome, Sidney Wolfe
Publikováno v:
Science (New York, N.Y.). 334(6061)
In his editorial “Rethinking clinical trials” (23 September, p. [1679][1]), A. Grove proposes returning to the era before the enactment of the 1938 Federal Food, Drug, and Cosmetic Act, when new drugs were marketed in the United States without ev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ca53b3027a3cd8b623d0060355f192e0
https://pubmed.ncbi.nlm.nih.gov/21940863
https://pubmed.ncbi.nlm.nih.gov/21940863
Publikováno v:
Clinical Pharmacokinetics. 53:1055-1056
In a recent article, Scheen [1] reviews the hepatic safety of incretin-based medications. The author concluded that ‘‘no hepatotoxicity has been reported in the development programme of alogliptin,’’ citing a review article from 2010, the yea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::212bbf667cc3cf35bf8416876d76bb65
https://doi.org/10.1007/s40262-014-0199-1
https://doi.org/10.1007/s40262-014-0199-1
Autor:
Sidney Wolfe, Michael Carome
Publikováno v:
JAMA. 305:1857
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f4fcf5eb3c6cc46d85ea5c3fe3ebe022
https://doi.org/10.1001/jama.2011.579
https://doi.org/10.1001/jama.2011.579